Lung Cancer Diagnostics Market To Witness Growth Based On Rising Awareness Levels Amongst The Population To Act As Major Growth Fcator Till 2024: Grand View Research, Inc.

The global lung cancer diagnostics market is expected to reach USD 3,644.6 million by 2024, according to a new report by Grand View Research Inc. The development of lung cancer-specific biomarkers is one of the primary factors for the growth of the lung cancer diagnostics market over the forecast period. These diagnostic tools facilitate the personalized treatment approach of lung malignancies. 

Various biomarkers are present in the research pipeline. For instance, in November 2015, Epigenomics AG announced the launch of a new blood-based test using DNA methylation biomarkers, the development of which is underway. The initial results of this test revealed a promising outcome in the early diagnosis of lung cancer. 

Furthermore, various awareness programs focusing on lung cancer and its associated symptoms are initiated in an attempt to elevate the screening and diagnosis rates inindividuals at a high risk of developing lung malignancies. For instance, November is considered as a lung cancer awareness month across the UK, which is supported by the Roy Castle Lung Cancer Foundation. 

Browse full research report on Global Lung Cancer Diagnostics  Market: http://www.grandviewresearch.com/industry-analysis/lung-cancer-diagnostics-market

Further key findings from the study suggest:

Read detailed report or request for sample of this research report:                 
http://www.grandviewresearch.com/industry-analysis/lung-cancer-diagnostics-market/request

 Grand View Research has segmented the global lung cancer diagnostics market on the basis of type, test, and region:

Global Lung Cancer Diagnostics Type Outlook (Revenue, USD Million, 2016 – 2024)

Global Lung Cancer Diagnostics Test Outlook (Revenue, USD Million, 2016 – 2024)

Lung Cancer Diagnostics Regional Outlook (Revenue, USD Million, 2016 – 2022)

Browse more reports of this category by Grand View  Research: http://www.grandviewresearch.com/industry/clinical-diagnostics

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc

Web: www.grandviewresearch.com

Read our blogs - legalworkshop.org, grandviewresearch.com/blogs/healthcare

0 rating(s) (0 ø)
Views: 94

All rights reserved

• This document may not be used, copied nor changed without explicit consent of the author.
Copyright Icon
The maximum length of a comment is 1000 characters.
The maximum length of an alias is 30 characters.
Please enter a comment.
Please insert a valid comment!